Pharmafile Logo
Pharmafocus logo
Advanced Search
BIS

UK second in global innovation index

September 18, 2015
Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo

The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …

News
266812

Jamie McGarvey joins Astellas Pharma communications team

September 18, 2015
Medical Communications Astellas, Astellas Pharma, Jamie McGarvey

Astellas Pharma has appointed Jamie McGarvey as senior manager of employee communications within its corporate affairs department.  McGarvey will be …

Appointment
BioInject

Sandoz opens €150m manufacturing facility

September 18, 2015
Manufacturing and Production Austria, BioInject, Novartis, Sandoz

Sandoz has opened a €150m state-of-the-art biopharmaceutical manufacturing facility in Schaftenau, Austria.  Known as BioInject will result in the creation …

News
AstraZeneca_drug_discovery

AstraZeneca and US Government collaborate to develop new antibiotics

September 17, 2015
Research and Development AstraZeneca, Azactam, BARDA, Department of Health and Human Services, HHHS, avibactam, aztreonam

AstraZeneca has entered into a public-private partnership with the US Department of Health and Human Services to develop drugs to …

News
eugene_van_rensburg-astellas

Astellas Pharma EMEA appoints new chief financial officer

September 17, 2015
Sales and Marketing Astellas, Eugene Van Rensburg

Astellas Pharma Europe, Middle East and Africa has appointed Eugene Van Rensburg to the position of chief financial officer, from …

Appointment
Abraxane

NICE says Celgene’s Abraxane is ‘too expensive for pancreatic cancer’

September 17, 2015
Sales and Marketing Abraxane, Celgene, NICE, Pancreatic cancer

NICE has decided not to recommend Abraxane (nab-paclitaxel) by Celgene in combination with gemcitabine for adults with metastatic pancreatic cancer.In …

News
ABPI

PMPCA rules on multiple pharma code breaches

September 17, 2015
Medical Communications, Sales and Marketing ABPI, ABPI Code, PMCPA, Prescriptions Medicine Code of Practice Authority

The industry’s code of conduct regulator has ruled on several alleged breaches of the ABPI code of pharmaceutical conduct by …

News
avastin_24

Cancer Drugs Fund ‘not sustainable in current form’

September 17, 2015
CDF, Cancer Drugs Fund, Department of Health, NHS England, National Audit Office, Public Accounts Committe, Roche, avastin

The Cancer Drugs Fund has improved access to treatments, although the UK still lags behind other countries despite its ‘unsustainable’ …

News
Amgen

Amgen joins M&A rush with deals for Dezima and Xencor

September 16, 2015
Research and Development, Sales and Marketing Amgen, Cancer, Denzime, Xencor, cardiovascular disease, high cholesterol, inflammation

Amgen has struck deals that could potentially be worth $3.25 billion, to purchase the Dutch firm Dezima and kick-off a …

News
Farydak

NICE rejects Farydak for multiple myeloma

September 16, 2015
Sales and Marketing Farydak, NICE, Novartis, multiple myeloma, panobinostat

NICE has rejected Novartis Farydak in its draft guidance, ruling it out as a treatment for multiple myeloma. Farydak (panobinostat) is …

News
PHE logo

Cancers diagnosed earlier in England, but cases rise

September 16, 2015
Cancer, Jeremy Hunt, Public Health England, cancer diagnosis, public health

The proportion of cancers diagnosed by GPs under the ‘two-week wait’ referral pathway rose, and late diagnoses fell, after the …

News
robert_califf

President Obama nominates Dr Robert Califf as new FDA head

September 16, 2015
Manufacturing and Production, Medical Communications

US President Barack Obama has put forward Dr Robert Califf as the next commissioner of the FDA, according to a …

Appointment
diabetes_injection

Sanofi’s LixiLan meets target in Phase III diabetes trial

September 16, 2015
Research and Development Lantus, LixiLan, Lixisenatide, Lxyumia, Sanofi, diabetes, insulin glargine, metformin, type 2 diabetes

Sanofi’s Phase III clinical trial of its Lixilan treatment has achieved its primary endpoint in patients with type 2 diabetes, …

News
clinical trial

The biggest side-effect of making medicine

September 16, 2015
Research and Development evergreening, intellectual property, patent

International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people …

Feature

R&D firms team up to tackle antibiotic resistance

September 16, 2015
Research and Development AMR, Antibiotics, Jim O'Neill, O'Neill review, antimicrobial resistance, drug development

Two companies at the centre of the UK’s R&D efforts to tackle the growing threat of resistance to antibiotics are expanding …

News
forxiga

AstraZeneca scores positive real-world Forxiga data

September 16, 2015
Research and Development AstraZeneca, EASD, European Association for the Study of Diabetes, Forxiga, dapagliflozin, exenatide, real world data, real world evidence

The real-world study of AstraZeneca’s diabetes drug Forxiga has found its use in UK patients primary care patients supports the …

News
GSK Worthing

GSK recalls 427,000 antibiotics after contamination scare

September 15, 2015
Manufacturing and Production Bactroban, FDA, GSK, manufacturing, product recalls, production, recalls

GlaxoSmithKline has had to recall more than 427,000 tubes of creams and ointments due to potential penicillin cross-contamination and the …

News

Sanofi to significantly expand UK inhaler plant

September 15, 2015
Manufacturing and Production Cheshire, Sanofi, manufacturing, production

Sanofi is gearing up for significant expansion of its inhaler production complex in Cheshire, England. The French pharma giant has …

News
astrazeneca image

AstraZeneca purchases former Amgen US facility

September 15, 2015
Manufacturing and Production Amgen, AstraZeneca, US, biologics, manufacturing, production

AstraZeneca has bolstered its US presence with the purchase of a high-tech biologics manufacturing facility from pharma rival Amgen. The …

News
mike_maclean

PureTech appoints Michael MacLean as chief financial officer

September 14, 2015
Medical Communications, Research and Development, Sales and Marketing Michael MacLean, PureTech Health

PureTech Health has appointed Michael MacLean to the management team, as chief financial officer and executive vice president. Michael MacLean …

Appointment
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026